Edward Miller
General Counsel at ALLOVIR, INC.
Net worth: 407 436 $ as of 2024-04-29
Edward Miller active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALLOVIR, INC. | General Counsel | 2018-12-31 | - |
| Corporate Secretary | 2018-12-31 | - |
Career history of Edward Miller
Former positions of Edward Miller
| Companies | Position | Start | End |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Compliance Officer | 2014-09-16 | 2017-04-30 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | General Counsel | 1999-12-31 | 2013-12-31 |
| ELOXX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - | - |
| Director of Finance/CFO | - | - |
Training of Edward Miller
| Princeton University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| General Counsel | 2 |
| Compliance Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Edward Miller
- Experience
